Home healthcare market forecast to reach USD 517.2 billion by
2025
“The global home healthcare market size was valued at USD 244.4 billion in 2015
and is expected to grow at a CAGR of 7.8% from 2014 to 2025. Increasing adoption
of telehealth and other emerging technologies are expected to drive market growth
over the forecast period”
The global home healthcare market is expected to reach USD 517.2 billion by
2025, according to a new report by Grand View Research, Inc. Home healthcare
products are generally applied to a broad range of equipment and services designed
for exclusive use for home or other non-medical establishments by non-professional
caregivers, family members, or the patients themselves.
Detailed Research Report available at:
http://www.grandviewresearch.com/industry-analysis/home-healthcare-industry
Increasing adoption of telehealth and other emerging technologies are expected to
drive market growth over the forecast period. Home healthcare is rapidly getting
adopted as a cost effective alternative to healthcare establishment based therapy and
Follow Us:
therefore, growing geriatric population base and prevalence of chronic conditions
requiring long term care is also expected to have a positive impact on growth.
Presence of untapped potential in emerging markets such as India, Brazil and China
and increasing health awareness are expected to serve home healthcare market as
future growth opportunities.
Further key findings from the study suggest:

Home healthcare services dominated the component segment, accounting for
over 85.0% of global revenue in 2015.

Infusion therapy is expected to be the fastest growing services market.
Increasing initiatives undertaken by medical service providers to curb costs
associated with specialty drugs and by retail pharmacies to render efficient
chronic disease management solutions are some of the drivers of this market.

Home healthcare based diagnostics held lucrative share in the equipment
segment accounting around 40.0% in 2015.

North America was the largest regional market in 2015, accounting for over
40.0% of the revenue. Presence of sophisticated medical systems and
reimbursement infrastructure, high patient awareness levels and healthcare
expenditure are some of the factors accounting for its substantial share.

Asia Pacific home healthcare market is expected to grow at the fastest CAGR of
around 9.0% from 2016 to 2024 majorly owing to high unmet medical needs
coupled with rapidly improving health infrastructure.

Major players in this vertical include Almost Family Inc., B. Braun Melsungen AG,
Abbott Laboratories, Sunrise Medical Inc., 3M Health Care, Baxter, Medtronic,
Cardinal Health Inc., Roche diagnostics corp., Air Liquide, Arcadia Health Care,
Bayer AG, Amedisys, Inc., Nxstage Medical, Inc., and Arkray Inc.
Follow Us:
Read our blog on Home Healthcare market:
http://www.grandviewresearch.com/blog/home-healthcare-market-size-trends
Table of content of global home Healthcare market research report:
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Home Healthcare Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Market Driver Analysis
3.3. Penetration & Growth Prospect Mapping
3.4. SWOT Analysis, By Factor
3.4.1. Political
3.4.2. Economic
3.4.3. Technological
Follow Us:
3.5. Industry Analysis - Porter’s
Chapter 4. Home Healthcare Component Estimates & Trend Analysis
4.1. Home Healthcare Movement Analysis & Market Share, 2015 & 2025
4.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 to
2025 (USD Billion) for the Following Components:
4.2.1. Equipment
4.2.1.1. Therapeutic
4.2.1.1.1. Home Respiratory Equipment
4.2.1.1.2. Insulin Delivery Device
4.2.1.1.3. Home IV Pumps
4.2.1.1.4. Home Dialysis Equipment
4.2.1.1.5. Other Therapeutic Equipment
4.2.1.2. Diagnostics
4.2.1.2.1. Diabetic Care Unit
4.2.1.2.2. BP Monitors
4.2.1.2.3. Multi Parameter Diagnostic Monitors
4.2.1.2.4. Home Pregnancy and Fertility Kits
Follow Us:
4.2.1.2.5. Other Self-Monitoring Equipment
4.2.1.2.6. Apnea and Sleep Monitors
4.2.1.2.7. Holter Monitors
4.2.1.2.8. Heart Rate Maters
4.2.1.2.9. Other
4.2.1.3. Mobility Assists
4.2.1.3.1. Rehabilitation Services
4.2.1.3.2. Unskilled Home Care
4.2.1.3.3. Respiratory Therapy Services
4.2.1.3.4. Infusion Therapy Services
4.2.1.3.5. Telemetry
4.2.2. Services
4.2.2.1.1. Rehabilitation Services
4.2.2.1.2. Unskilled Home Care
4.2.2.1.3. Respiratory Therapy Services
4.2.2.1.4. Infusion Therapy Services
4.2.2.1.5. Telemetry
Follow Us:
Chapter 5. Home Healthcare Regional Estimates & Trend Analysis
5.1. Regional Movement Analysis & Market Share, 2015 & 2025
5.2. North America
5.2.1. U.S.
5.2.1.1. U.S. revenue estimates and forecasts by, component (USD
Billion) 2014 - 2025
5.2.2. Canada
5.2.2.1. Canada revenue estimates and forecasts by, component
(USD Billion) 2014 - 2025
5.3. Europe
5.3.1. UK
5.3.1.1. UK revenue estimates and forecasts by, component (USD
Billion) 2014 - 2025
5.3.2. Germany
5.3.2.1. Germany revenue estimates and forecasts by, component
(USD Billion) 2014 - 2025
5.4. Asia Pacific
5.4.1. Japan
Follow Us:
5.4.1.1. Japan revenue estimates and forecasts by, component
(USD Billion) 2014 - 2025
5.4.2. China
5.4.2.1. China revenue estimates and forecasts by, component
(USD Billion) 2014 - 2025
5.5. Latin America
5.5.1. Brazil
5.5.1.1. Brazil revenue estimates and forecasts by, component (USD
Billion) 2014 - 2025
5.5.2. Mexico
5.5.2.1. Mexico revenue estimates and forecasts by, component
(USD Billion) 2014 - 2025
5.6. MEA
5.6.1. South Africa
5.6.1.1. South Africa revenue estimates and forecasts by,
component (USD Billion) 2014 - 2025
Chapter 6. Competitive Landscape
6.1. Strategy Framework
6.2. Company Profiles
Follow Us:
6.2.1. Almost Family Inc.
6.2.1.1. Company Overview
6.2.1.2. Financial Performance
6.2.1.3. Product Benchmarking
6.2.1.4. Strategic Initiatives
6.2.2. B. Braun Melsungen AG
6.2.2.1. Company Overview
6.2.2.2. Financial Performance
6.2.2.3. Product Benchmarking
6.2.2.4. Strategic Initiatives
6.2.3. Abbott Laboratories
6.2.3.1. Company Overview
6.2.3.2. Financial Performance
6.2.3.3. Product Benchmarking
6.2.3.4. Strategic Initiatives
6.2.4. Sunrise Medical Inc.
6.2.4.1. Company Overview
Follow Us:
6.2.4.2. Financial Performance
6.2.4.3. Product Benchmarking
6.2.4.4. Strategic Initiatives
6.2.5. 3M Healthcare
6.2.5.1. Company Overview
6.2.5.2. Financial Performance
6.2.5.3. Product Benchmarking
6.2.5.4. Strategic Initiatives
6.2.6. Baxter International Inc.
6.2.6.1. Company Overview
6.2.6.2. Financial Performance
6.2.6.3. Product Benchmarking
6.2.6.4. Strategic Initiatives
6.2.7. Medtronic
6.2.7.1. Company Overview
6.2.7.2. Financial Performance
6.2.7.3. Product Benchmarking
Follow Us:
6.2.7.4. Strategic Initiatives
6.2.8. Cardinal Health Inc.
6.2.8.1. Company Overview
6.2.8.2. Financial Performance
6.2.8.3. Product Benchmarking
6.2.8.4. Strategic Initiatives
6.2.9. Roche Diagnostics Corp.
6.2.9.1. Company Overview
6.2.9.2. Financial Performance
6.2.9.3. Product Benchmarking
6.2.9.4. Strategic Initiatives
6.2.10. Roche Diagnostics Corp.
6.2.10.1. Company Overview
6.2.10.2. Financial Performance
6.2.10.3. Product Benchmarking
6.2.10.4. Strategic Initiatives
6.2.11. Roche Diagnostics Corp.
Follow Us:
6.2.11.1. Company Overview
6.2.11.2. Financial Performance
6.2.11.3. Product Benchmarking
6.2.11.4. Strategic Initiatives
6.2.12. Air Liquide
6.2.12.1. Company Overview
6.2.12.2. Financial Performance
6.2.12.3. Product Benchmarking
6.2.12.4. Strategic Initiatives
6.2.13. Arcadia Resources, Inc.
6.2.13.1. Company Overview
6.2.13.2. Financial Performance
6.2.13.3. Product Benchmarking
6.2.13.4. Strategic Initiatives
6.2.14. Bayer Healthcare AG
6.2.14.1. Company Overview
6.2.14.2. Financial Performance
Follow Us:
6.2.14.3. Product Benchmarking
6.2.14.4. Strategic Initiatives
6.2.15. Amedisys, Inc.
6.2.15.1. Company Overview
6.2.15.2. Financial Performance
6.2.15.3. Product Benchmarking
6.2.15.4. Strategic Initiatives
6.2.16. Nxstage Medical, Inc
6.2.16.1. Company Overview
6.2.16.2. Financial Performance
6.2.16.3. Product Benchmarking
6.2.16.4. Strategic Initiatives
6.2.17. Arkray Inc.
6.2.17.1. Company Overview
6.2.17.2. Financial Performance
6.2.17.3. Product Benchmarking
6.2.17.4. Strategic Initiatives
Follow Us:
6.2.18. Apria Healthcare Group
6.2.18.1. Company Overview
6.2.18.2. Financial Performance
6.2.18.3. Product Benchmarking
6.2.18.4. Strategic Initiatives
6.2.19. Odyssey Healthcare Inc.
6.2.19.1. Company Overview
6.2.19.2. Financial Performance
6.2.19.3. Product Benchmarking
6.2.19.4. Strategic Initiatives
6.2.20. Becton, Dickinson and Company
6.2.20.1. Company Overview
6.2.20.2. Financial Performance
6.2.20.3. Product Benchmarking
6.2.20.4. Strategic Initiatives
6.2.21. Critical Homecare
6.2.21.1. Company Overview
Follow Us:
6.2.21.2. Financial Performance
6.2.21.3. Product Benchmarking
6.2.21.4. Strategic Initiatives
6.2.22. National Healthcare Corp.
6.2.22.1. Company Overview
6.2.22.2. Financial Performance
6.2.22.3. Product Benchmarking
6.2.22.4. Strategic Initiatives
6.2.23. Omron Healthcare, Inc.
6.2.23.1. Company Overview
6.2.23.2. Financial Performance
6.2.23.3. Product Benchmarking
6.2.23.4. Strategic Initiatives
6.2.24. Drive Medical Design & Manufacturing
6.2.24.1. Company Overview
6.2.24.2. Financial Performance
6.2.24.3. Product Benchmarking
Follow Us:
6.2.24.4. Strategic Initiatives
6.2.25. Chubb Community Care
6.2.25.1. Company Overview
6.2.25.2. Financial Performance
6.2.25.3. Product Benchmarking
6.2.25.4. Strategic Initiatives
6.2.26. Gambro AB
6.2.26.1. Company Overview
6.2.26.2. Financial Performance
6.2.26.3. Product Benchmarking
6.2.26.4. Strategic Initiatives
6.2.27. GE Healthcare
6.2.27.1. Company Overview
6.2.27.2. Financial Performance
6.2.27.3. Product Benchmarking
6.2.27.4. Strategic Initiatives
6.2.28. Medline Industries Inc.
Follow Us:
6.2.28.1. Company Overview
6.2.28.2. Financial Performance
6.2.28.3. Product Benchmarking
6.2.28.4. Strategic Initiatives
6.2.29. Philips Healthcare
6.2.29.1. Company Overview
6.2.29.2. Financial Performance
6.2.29.3. Product Benchmarking
6.2.29.4. Strategic Initiatives
6.2.30. Medco Health Solutions Inc.
6.2.30.1. Company Overview
6.2.30.2. Financial Performance
6.2.30.3. Product Benchmarking
6.2.30.4. Strategic Initiatives
6.2.31. Graham-Field Health Products Inc.
6.2.31.1. Company Overview
6.2.31.2. Financial Performance
Follow Us:
6.2.31.3. Product Benchmarking
6.2.31.4. Strategic Initiatives
6.2.32. Hill-Rom Holdings Inc.
6.2.32.1. Company Overview
6.2.32.2. Financial Performance
6.2.32.3. Product Benchmarking
6.2.32.4. Strategic Initiatives
6.2.33. Gentiva Health Services Inc
6.2.33.1. Company Overview
6.2.33.2. Financial Performance
6.2.33.3. Product Benchmarking
6.2.33.4. Strategic Initiatives
6.2.34. Johnson & Johnson
6.2.34.1. Company Overview
6.2.34.2. Financial Performance
6.2.34.3. Product Benchmarking
6.2.34.4. Strategic Initiatives
Follow Us:
6.2.35. Linde Healthcare
6.2.35.1. Company Overview
6.2.35.2. Financial Performance
6.2.35.3. Product Benchmarking
6.2.35.4. Strategic Initiatives
6.2.36. Lincare Holdings, Inc.
6.2.36.1. Company Overview
6.2.36.2. Financial Performance
6.2.36.3. Product Benchmarking
6.2.36.4. Strategic Initiatives
6.2.37. Kinetic Concepts
6.2.37.1. Company Overview
6.2.37.2. Financial Performance
6.2.37.3. Product Benchmarking
6.2.37.4. Strategic Initiatives
6.2.38. Carefusion
6.2.38.1. Company Overview
Follow Us:
6.2.38.2. Financial Performance
6.2.38.3. Product Benchmarking
6.2.38.4. Strategic Initiatives
6.2.39. Vygon
6.2.39.1. Company Overview
6.2.39.2. Financial Performance
6.2.39.3. Product Benchmarking
6.2.39.4. Strategic Initiatives
6.2.40. Teleflex
6.2.40.1. Company Overview
6.2.40.2. Financial Performance
6.2.40.3. Product Benchmarking
6.2.40.4. Strategic Initiatives
6.2.41. Moog Inc.
6.2.41.1. Company Overview
6.2.41.2. Financial Performance
6.2.41.3. Product Benchmarking
Follow Us:
6.2.41.4. Strategic Initiatives
6.2.42. Intersurgical
6.2.42.1. Company Overview
6.2.42.2. Financial Performance
6.2.42.3. Product Benchmarking
6.2.42.4. Strategic Initiatives
6.2.43. Fresenius Kabi
6.2.43.1. Company Overview
6.2.43.2. Financial Performance
6.2.43.3. Product Benchmarking
6.2.43.4. Strategic Initiatives
Follow Us:
About Grand View Research, Inc.:
Grand View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, the company offers
market intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: [email protected]
Web – http://www.grandviewresearch.com/
Follow Us:

The global home healthcare market is expected to reach USD 517.2 billion by 2025, according to a new report by Grand View Research, Inc. Home healthcare products are generally applied to a broad range of equipment and services designed for exclusive use for home or other non-medical establishments by non-professional caregivers, family members, or the patients themselves. Click here - http://www.grandviewresearch.com/industry-analysis/home-healthcare-industry

North America Hemodialysis Devices Industry- Size, Share and Market Forecasts 2021